Keratinocyte growth factor (KGF) is a mitogen found throughout the gas
trointestinal tract, but its role in gastrointestinal pathophysiology
is unclear. The effect of recombinant KGF on gut growth and repair has
been examined using a variety of in vivo models. Rats receiving total
parenteral nutrition had co-infusions of KGF or control for 6 days. C
hanges in gut growth (wet weight and vincristine-induced metaphase arr
est) were then assessed. The effects of KGF on gastric repair and acid
secretion in rats tr ere determined using an indomethacin (20 mg/kg)/
restraint model and animals fitted with chronic gastric fistulae. KGF
at 0.1, 1, and 3 mg/kg increased gut growth as assessed by wet weight
throughout the gastrointestinal tract and increased vincristine-induce
d accumulation of metaphases in the stomach and small intestine but no
t in the colon. Plasma gastrin, peptide YY, enteroglucagon, and glucag
on-like peptide-1 were all increased, whereas insulin was lowered by K
GF (all P<0.01). KGF was ineffective in reducing indomethacin-induced
gastric damage but caused a reduction in basal acid secretion of about
35 and 50 per cent when administered at 0.2 or 5 mg/kg (P<0.05). Thes
e studies support the idea that KGF is involved in the control of prol
iferation of the gastrointestinal tract. They do not provide evidence,
however, for a role in the early reparative process invoked during sh
ort-term models of gastrointestinal injury. (C) 1998 John Wiley & Sons
, Ltd.